
Neogen Corp
NASDAQ:NEOG

Net Margin
Neogen Corp
Net Margin measures how much net income is generated as a percentage of revenues received. It helps investors assess if a company's management is generating enough profit from its sales and whether operating costs and overhead costs are being contained.
Net Margin Across Competitors
Country | Company | Market Cap |
Net Margin |
||
---|---|---|---|---|---|
US |
![]() |
Neogen Corp
NASDAQ:NEOG
|
1.1B USD |
-54%
|
|
CH |
![]() |
Alcon AG
SIX:ALC
|
35.3B CHF |
11%
|
|
JP |
![]() |
Hoya Corp
TSE:7741
|
6.4T JPY |
23%
|
|
DK |
![]() |
Coloplast A/S
CSE:COLO B
|
138.4B DKK |
16%
|
|
US |
![]() |
Align Technology Inc
NASDAQ:ALGN
|
14.5B USD |
10%
|
|
CH |
![]() |
Ypsomed Holding AG
SIX:YPSN
|
5.8B CHF |
12%
|
|
UK |
![]() |
ConvaTec Group PLC
LSE:CTEC
|
5B GBP |
8%
|
|
CN |
![]() |
Shenzhen New Industries Biomedical Engineering Co Ltd
SZSE:300832
|
42.6B CNY |
40%
|
|
CA |
![]() |
Bausch + Lomb Corp
NYSE:BLCO
|
5B USD |
-8%
|
|
US |
![]() |
Lantheus Holdings Inc
NASDAQ:LNTH
|
5B USD |
17%
|
|
US |
![]() |
Merit Medical Systems Inc
NASDAQ:MMSI
|
5B USD |
9%
|
Neogen Corp
Glance View
Founded in 1982, Neogen Corp. has steadily carved out its niche at the intersection of food safety and animal health, positioning itself as a vital player in agricultural diagnostics. The company's journey began in Lansing, Michigan, where it initially focused on innovative solutions to meet the growing demands of food safety and quality testing. By developing rapid tests for detecting foodborne bacteria and allergens, Neogen tapped into a critical market, addressing the increasing concerns about food safety amidst a complex global supply chain. This foundation in diagnostics set the stage for the growth Neogen would see over the ensuing decades. As Neogen expanded, it strategically diversified its offerings, moving beyond food safety into the broader realm of animal health. This expansion was not merely about developing products; it was about advancing the means by which farms and food producers monitor and ensure the health of their livestock and crops. The company's profits flow from the sale of its diagnostic products, which help minimize risks associated with food contamination and animal diseases. By providing a suite of solutions, from DNA testing for genetic traits and diseases in cattle to disinfectants and rodenticides that maintain farm hygiene, Neogen creates value for its clients by increasing their operational efficiency and safeguarding public health. This strategic blend of food safety and animal health products places Neogen at the heart of modern agricultural and food production systems, where safety and efficiency are paramount.

See Also
Net Margin measures how much net income is generated as a percentage of revenues received. It helps investors assess if a company's management is generating enough profit from its sales and whether operating costs and overhead costs are being contained.
Based on Neogen Corp's most recent financial statements, the company has Net Margin of -53.6%.